Financière de Tubize SA (BST:FTD)

Germany flag Germany · Delayed Price · Currency is EUR
199.00
+2.40 (1.22%)
At close: May 19, 2026
Market Cap8.90B +66.3%
Revenue (ttm)n/a
Net Income93.23M +3.5%
EPS2.09 +3.5%
Shares Outn/a
PE Ratio95.44
Forward PEn/a
Dividend0.76 (0.37%)
Ex-Dividend DateMay 7, 2026
Volumen/a
Average Volumen/a
Open195.80
Previous Close196.60
Day's Range195.70 - 202.40
52-Week Range131.80 - 250.00
Betan/a
RSI40.33
Earnings DateMar 21, 2026

About Financière de Tubize

Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium. [Read more]

Industry Investors, not elsewhere classified
Founded 1928
Employees 3
Stock Exchange Stuttgart Stock Exchange
Ticker Symbol FTD

Financial Performance

Financial Statements

News

Financière de Tubize Earnings Call Transcript: H2 2025

Maintains a 36% stake in UCB, focusing on long-term value and readiness to support UCB's growth, with strong stock price and TSR performance driven by UCB's key products. Dividend growth slowed to 4% as reserves are prioritized for strategic flexibility.

2 months ago - Transcripts

Financière de Tubize Annual report: H2 2025

Financière de Tubize has published its H2 2025 annual report on March 23, 2026.

2 months ago - Filings

Financière de Tubize Earnings release: H1 2025

Financière de Tubize released its H1 2025 earnings on August 1, 2025, summarizing the period's financial results.

10 months ago - Filings

Financière de Tubize Quarterly report: H1 2025

Financière de Tubize has published its H1 2025 quarterly earnings report on August 1, 2025.

10 months ago - Filings